Bruce Cohen on Muck Rack

Bruce Cohen

United States
As seen in: Nature, Psychology Today, Variety, JAMA (The Journal of the American Medical Association), JAMA Network, Metro Weekly, Neurology, Neurology Journal, Dialnet - Universidad de La Rioja, The Salem News (Salem, MA) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bruce

Contact Bruce, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Why Are We Still Calling People ‘Schizophrenic’?

|
By Bruce Cohen, Peter Harris, Margaret Foley
| Psychology Today Verified
"Schizophrenia" appears frequently in the news. The New York Times website lists more than 6,000 articles mentioning schizophrenia. Sometimes, these are stories of research advances or care. Often, they are stories of despair or violence. Less than 1 percent of people have what official manuals for psychiatric diagnosis call "schizophrenia." However, diagnoses of schizophrenia are common in clinical settings.
Open in Who Shared Issue with article?

Occupational Experience Effects on Physiological and Perceptual Responses of Common Soldiering Tasks

|
By Bruce Cohen, Jan E. Redmond, Stephen A. Foulis, Caitlin C. Haven
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda Occupational Experience Effects on Physiological and Perceptual Responses of Common Soldiering Tasks Bruce S. Cohen [1] ; Jan E. Redmond [1] ; Caitlin C. Haven [1] ; Stephen A. Foulis [1] ; Maria C. Canino [1] ; Peter N. Frykman [1] ; Marilyn A.
Open in Who Shared Issue with article?

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial

|
By Amel Karaa, Enrico Bertini, Valerio Carelli, Bruce Cohen
| Texas Medical Center
BACKGROUND AND OBJECTIVES: Primary mitochondrial myopathies (PMMs) encompass a group of genetic disorders that impair mitochondrial oxidative phosphorylation, adversely affecting physical function, exercise capacity, and quality of life (QoL). Current PMM standards of care address symptoms, with limited clinical impact, constituting a significant therapeutic unmet need.
Open in Who Shared Issue with article?
See all 23 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified